CD274 and thyroid gland carcinoma: Our group and others have shown that BRAFV600E-mutant thyroid cancers have increased expression of Programmed Death Ligand 1 (PD-L1, CD274), a physiologic “checkpoint” expressed on tumour cells, macrophages, and other cell types.